Retirement Solutions Specialists
|
Great Lakes Pension Associates, Inc.
|
Defined Contribution Account Manager Nova 401(k) Associates
|
New York City District Council of Carpenters Benefit Funds
|
TPA Retirement Plan Consultant EPIC RPS (TPA/DPS)
|
Fringe Benefit Group
|
Pollard & Associates
|
Retirement Planners and Administrators (RPA)
|
Greenline Wealth Management
|
Defined Contributions Compliance Consultant Loren D. Stark Company (LDSCO)
|
Senior Specialist 401k Recordkeeping T Bank N.A.
|
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
Press Releases by Date | Press Releases by Company Name
View More Press Releases by Aon plc
Press Release Aon advises Rolls-Royce UK Pension Fund on the largest ever bulk annuity transaction |
Issued by Aon plc June 7, 2019 |
LONDON, (7 June 2019) - Aon plc (NYSE:AON), a leading global professional services firm providing a broad range of risk, retirement and health solutions, has advised the Trustee of the Rolls-Royce UK Pension Fund on a partial buyout in excess of £4.6billion with Legal & General Group Plc (Legal & General) - the largest ever UK buyout. The £13 billion Rolls-Royce UK Pension Fund has 76,000 members. This buyout covers around 33,000 members and included transferring to Legal & General the Fund's existing £3 billion longevity swap, on which Aon advised in 2011. Aon advised the Trustee throughout this transaction, both as its scheme actuary, and insurance & longevity adviser. Liz Airey, Chairman of the Trustee, said: Alastair McIntosh, principal consultant at Aon and lead actuarial adviser to the Trustee, said: Martin Bird, senior partner & head of Risk Settlement at Aon, said: "We are, of course, very pleased to have had the opportunity to support the Trustee on this ground-breaking transaction" John Baines, partner in Aon's Risk Settlement Group said: |
View More Press Releases by Aon plc
Editor's note: This press release has been issued by the company named above, not BenefitsLink. Reliance on information in this press release might be prudent only after an independent review of its accuracy, completeness, efficacy, and timeliness. Reference to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer, or otherwise does not constitute or imply endorsement, recommendation, or favoring by BenefitsLink. |